Xylem Inc. (NYSE:XYL) reached a new 52-week high during mid-day trading on Thursday . The stock traded as high as $48.81 and last traded at $48.68, with a volume of 442,776 shares traded. The stock had previously closed at $47.89.

Several equities research analysts have issued reports on XYL shares. Oppenheimer Holdings Inc. reiterated an “outperform” rating on shares of Xylem in a research note on Tuesday, April 19th. Wedbush upped their target price on shares of Xylem from $41.00 to $43.00 and gave the company a “neutral” rating in a research note on Wednesday, May 4th. Canaccord Genuity restated a “hold” rating and issued a $42.00 target price on shares of Xylem in a research note on Wednesday, May 4th. Royal Bank Of Canada upgraded shares of Xylem from a “sector perform” rating to an “outperform” rating and upped their target price for the company from $37.00 to $42.00 in a research note on Wednesday, June 1st. Finally, Zacks Investment Research downgraded shares of Xylem from a “buy” rating to a “hold” rating in a research note on Friday, July 15th. Nine analysts have rated the stock with a hold rating and five have given a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average target price of $42.25.

The company’s 50-day moving average price is $46.40 and its 200-day moving average price is $42.18. The company has a market cap of $8.70 billion and a PE ratio of 25.94.

Xylem (NYSE:XYL) last posted its quarterly earnings results on Tuesday, August 2nd. The company reported $0.48 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.47 by $0.01. The company earned $932 million during the quarter, compared to analysts’ expectations of $927.69 million. Xylem’s revenue for the quarter was up 1.3% compared to the same quarter last year. During the same period last year, the company earned $0.43 earnings per share. Analysts predict that Xylem Inc. will post $2.04 earnings per share for the current fiscal year.

In related news, Director Steven R. Loranger sold 50,000 shares of the firm’s stock in a transaction that occurred on Wednesday, June 1st. The shares were sold at an average price of $44.52, for a total transaction of $2,226,000.00. Following the transaction, the director now owns 12,588 shares of the company’s stock, valued at $560,417.76. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Steven R. Loranger sold 32,246 shares of the firm’s stock in a transaction that occurred on Thursday, July 28th. The shares were sold at an average price of $48.01, for a total transaction of $1,548,130.46. Following the transaction, the director now directly owns 38,334 shares in the company, valued at approximately $1,840,415.34. The disclosure for this sale can be found here.

A number of institutional investors have modified their holdings of XYL. KBC Group NV raised its position in shares of Xylem by 27.0% in the fourth quarter. KBC Group NV now owns 185,037 shares of the company’s stock valued at $6,754,000 after buying an additional 39,313 shares during the last quarter. BlackRock Advisors LLC raised its position in shares of Xylem by 11.8% in the fourth quarter. BlackRock Advisors LLC now owns 300,053 shares of the company’s stock valued at $10,952,000 after buying an additional 31,689 shares during the last quarter. Morgan Stanley raised its position in shares of Xylem by 2.3% in the fourth quarter. Morgan Stanley now owns 340,028 shares of the company’s stock valued at $12,411,000 after buying an additional 7,676 shares during the last quarter. Aberdeen Asset Management PLC UK raised its position in shares of Xylem by 24.9% in the fourth quarter. Aberdeen Asset Management PLC UK now owns 35,358 shares of the company’s stock valued at $1,259,000 after buying an additional 7,040 shares during the last quarter. Finally, Principal Financial Group Inc. raised its position in shares of Xylem by 0.8% in the fourth quarter. Principal Financial Group Inc. now owns 257,033 shares of the company’s stock valued at $9,381,000 after buying an additional 2,164 shares during the last quarter.

Xylem Inc is engaged in the design, manufacturing, and application of engineered technologies for the water industry. The Company is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.